Lysophosphatidic acid production and action: critical new players in breast cancer initiation and progression
Open Access
- 16 March 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in British Journal of Cancer
- Vol. 102 (6), 941-946
- https://doi.org/10.1038/sj.bjc.6605588
Abstract
Lysophosphatidic acid (LPA) is a potent lipid mediator that acts on a series of specific G protein-coupled receptors, leading to diverse biological actions. Lysophosphatidic acid induces cell proliferation, survival and migration, which are critically required for tumour formation and metastasis. This bioactive lipid is produced by the ectoenzyme lysophospholipase D or autotaxin (ATX), earlier known as an autocrine motility factor. The ATX–LPA signalling axis has emerged as an important player in many types of cancer. Indeed, aberrant expression of ATX and LPA receptors occurs during the development and progression of breast cancer. Importantly, expression of either ATX or LPA receptors in the mammary gland of transgenic mice is sufficient to induce the development of a high frequency of invasive and metastatic mammary cancers. The focus of research now turns to understanding the mechanisms by which ATX and LPA promote mammary tumourigenesis and metastasis. Targeting the ATX–LPA signalling axis for drug development may further improve outcomes in patients with breast cancer.Keywords
This publication has 46 references indexed in Scilit:
- Identification and Characterization of a Novel Lysophosphatidic Acid Receptor, p2y5/LPA6Journal of Biological Chemistry, 2009
- The Absence of LPA2 Attenuates Tumor Formation in an Experimental Model of Colitis-Associated CancerGastroenterology, 2009
- Hsp90 inhibitor PU-H71, a multimodal inhibitor of malignancy, induces complete responses in triple-negative breast cancer modelsProceedings of the National Academy of Sciences of the United States of America, 2009
- Autotaxin/Lysopholipase D and Lysophosphatidic Acid Regulate Murine Hemostasis and ThrombosisOnline Journal of Public Health Informatics, 2009
- Breast cancer risk in elderly women with systemic autoimmune rheumatic diseases: a population-based case–control studyBritish Journal of Cancer, 2009
- Lysophosphatidic Acid Receptors Determine Tumorigenicity and Aggressiveness of Ovarian Cancer CellsJNCI Journal of the National Cancer Institute, 2008
- Carba Analogs of Cyclic Phosphatidic Acid Are Selective Inhibitors of Autotaxin and Cancer Cell Invasion and MetastasisOnline Journal of Public Health Informatics, 2006
- Autotaxin, a Secreted Lysophospholipase D, Is Essential for Blood Vessel Formation during DevelopmentMolecular and Cellular Biology, 2006
- The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastasesProceedings of the National Academy of Sciences of the United States of America, 2006
- The emerging role of lysophosphatidic acid in cancerNature Reviews Cancer, 2003